| A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non–small cell lung cancer DL Rimm, G Han, JM Taube, SY Eunhee, JA Bridge, DB Flieder, R Homer, ... JAMA oncology 3 (8), 1051-1058, 2017 | 788 | 2017 |
| Uric acid in metabolic syndrome: from an innocent bystander to a central player M Kanbay, T Jensen, Y Solak, M Le, C Roncal-Jimenez, C Rivard, ... European journal of internal medicine 29, 3-8, 2016 | 457 | 2016 |
| High‐fat and high‐sucrose (western) diet induces steatohepatitis that is dependent on fructokinase T Ishimoto, MA Lanaspa, CJ Rivard, CA Roncal‐Jimenez, DJ Orlicky, ... Hepatology 58 (5), 1632-1643, 2013 | 384 | 2013 |
| Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice T Ishimoto, MA Lanaspa, MPT Le, GE Garcia, CP Diggle, PS MacLean, ... Proceedings of the National Academy of Sciences 109 (11), 4320-4325, 2012 | 329 | 2012 |
| Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver MA Lanaspa, LG Sanchez-Lozada, C Cicerchi, N Li, CA Roncal-Jimenez, ... PloS one 7 (10), e47948, 2012 | 315 | 2012 |
| Fructokinase activity mediates dehydration-induced renal injury CAR Jimenez, T Ishimoto, MA Lanaspa, CJ Rivard, T Nakagawa, AA Ejaz, ... Kidney international 86 (2), 294-302, 2014 | 297 | 2014 |
| LAG-3 protein expression in non–small cell lung cancer and its relationship with PD-1/PD-L1 and tumor-infiltrating lymphocytes Y He, H Yu, L Rozeboom, CJ Rivard, K Ellison, R Dziadziuszko, K Suda, ... Journal of Thoracic Oncology 12 (5), 814-823, 2017 | 272 | 2017 |
| Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome MA Lanaspa, T Ishimoto, N Li, C Cicerchi, DJ Orlicky, P Ruzycki, C Rivard, ... Nature communications 4 (1), 2434, 2013 | 258 | 2013 |
| Abnormal angiogenesis in diabetic nephropathy T Nakagawa, T Kosugi, M Haneda, CJ Rivard, DA Long Diabetes 58 (7), 1471, 2009 | 252 | 2009 |
| Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis EH Garin, W Mu, JM Arthur, CJ Rivard, CE Araya, M Shimada, ... Kidney International 78 (3), 296-302, 2010 | 237 | 2010 |
| Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes … DI Jalal, CJ Rivard, RJ Johnson, DM Maahs, K McFann, M Rewers, ... Nephrology Dialysis Transplantation 25 (6), 1865-1869, 2010 | 225 | 2010 |
| Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver MA Lanaspa, C Cicerchi, G Garcia, N Li, CA Roncal-Jimenez, CJ Rivard, ... PloS one 7 (11), e48801, 2012 | 219 | 2012 |
| Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake CA Roncal-Jimenez, MA Lanaspa, CJ Rivard, T Nakagawa, ... Metabolism 60 (9), 1259-1270, 2011 | 217 | 2011 |
| Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids C Cicerchi, N Li, J Kratzer, G Garcia, CA Roncal-Jimenez, K Tanabe, ... The FASEB Journal 28 (8), 3339, 2014 | 210 | 2014 |
| Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects MPT Le, RF Frye, CJ Rivard, J Cheng, KK McFann, MS Segal, ... Metabolism 61 (5), 641-651, 2012 | 202 | 2012 |
| Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer Y He, CJ Rivard, L Rozeboom, H Yu, K Ellison, A Kowalewski, C Zhou, ... Cancer science 107 (9), 1193-1197, 2016 | 199 | 2016 |
| The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized … M Madero, JC Arriaga, D Jalal, C Rivard, K McFann, O Pérez-Méndez, ... Metabolism 60 (11), 1551-1559, 2011 | 198 | 2011 |
| HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib Y Wang, T Jiang, Z Qin, J Jiang, Q Wang, S Yang, C Rivard, G Gao, TL Ng, ... Annals of Oncology 30 (3), 447-455, 2019 | 192 | 2019 |
| Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy MA Lanaspa, T Ishimoto, C Cicerchi, Y Tamura, CA Roncal-Jimenez, ... Journal of the American Society of Nephrology 25 (11), 2526-2538, 2014 | 191 | 2014 |
| Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial JE Chaft, F Oezkan, MG Kris, PA Bunn, II Wistuba, DJ Kwiatkowski, ... Nature medicine 28 (10), 2155-2161, 2022 | 183 | 2022 |